SEC Form 4 · Updated Daily
ALNY
— ALNYLAM PHARMACEUTICALS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| SANOFI-AVENTIS | 10%+ Owner | 10,554,134 | 2017-05-31 | P |
| NOVARTIS AG | 10%+ Owner | 4,051,002 | 2012-09-20 | S |
| NOVARTIS INC | 10%+ Owner | 4,051,002 | 2012-09-20 | S |
| ATLAS VENTURE ENTREPRENEURS FUND VI LP | 10%+ Owner | 747,580 | 2006-02-24 | S |
| ATLAS VENTURE FUND V LP | 10%+ Owner | 747,580 | 2006-02-24 | S |
| Atlas Venture Associates VI, L.P. | 10%+ Owner | 747,580 | 2006-02-24 | S |
| Atlas Venture Fund VI GmbH & Co KG | 10%+ Owner | 747,580 | 2006-02-24 | S |
| ATLAS VENTURE ENTREPRENEURS FUND V LP | 10%+ Owner | 747,580 | 2006-02-24 | S |
| ATLAS VENTURE FUND VI LP | 10%+ Owner | 747,580 | 2006-02-24 | S |
| ATLAS VENTURE ASSOCIATES V LP | 10%+ Owner | 747,580 | 2006-02-24 | S |
| ATLAS VENTURE PARALLEL FUND V-A C V | 10%+ Owner | 747,580 | 2006-02-24 | S |
| Barrett Peter | Director | 289,024 | 2006-03-07 | S |
| MARAGANORE JOHN | Director | 234,299 | 2021-12-21 | A |
| Greene Barry E | Director | 114,873 | 2020-09-09 | M |
| Greenstreet Yvonne | Director · Officer | 95,802 | 2026-09-19 | A |
| Poulton Jeffrey V. | Officer | 64,159 | 2026-03-04 | S |
| STARR KEVIN P | 10%+ Owner | 37,500 | 2015-11-12 | M |
| Tanguler Tolga | Officer | 36,500 | 2026-03-04 | S |
| BONNEY MICHAEL W | Director | 28,054 | 2025-08-18 | M |
| SCHIMMEL PAUL | Director | 27,823 | 2018-03-13 | M |
| Vaishnaw Akshay | Director | 26,831 | 2023-08-03 | A |
| Allen Patricia L | Director | 25,000 | 2009-04-22 | M |
| SCHULMAN AMY W | 10%+ Owner | 24,049 | 2026-05-20 | A |
| CLARKE JOHN K | Director | 23,891 | 2018-05-31 | M |
| Garg Pushkal | Officer | 23,300 | 2026-03-04 | S |
| Fitzgerald Kevin Joseph | Officer | 21,831 | 2026-03-04 | S |
| Reid Laurence | Officer | 20,905 | 2014-12-31 | M |
| PAUL STEVEN M | Director | 16,000 | 2022-04-01 | M |
| KEATING LAURIE | Officer | 15,132 | 2021-08-05 | M |
| McLaughlin Melissa | Officer | 13,088 | 2026-04-02 | S |
| SUPRAN BRYAN | Officer | 12,807 | 2026-10-02 | S |
| VINCENT JAMES L | Director | 12,100 | 2010-06-18 | M |
| SHARP PHILLIP A | Director | 11,250 | 2025-01-23 | M |
| Hesslein Robert W. | Officer | 8,002 | 2025-03-03 | A |
| PYOTT DAVID E I | Director | 5,412 | 2026-06-01 | M |
| Franchini Indrani Lall | Officer | 4,462 | 2024-02-27 | M |
| HAMBURG MARGARET A | Director | 1,582 | 2026-05-20 | A |
| Ausiello Dennis A | Director | 1,582 | 2026-05-20 | A |
| BRANDICOURT OLIVIER | Director | 1,446 | 2026-05-20 | A |
| Sigal Charles Elliott | Director | 1,446 | 2026-05-20 | A |
| KELLOGG PETER N | Director | 1,446 | 2026-05-20 | A |
| Reitan Colleen F | Director | 1,446 | 2026-05-20 | A |
| Mason Michael | Officer | 1,012 | 2018-08-13 | A |
| Gros David-Alexandre C | Officer | 1,000 | 2016-02-22 | P |
| Bertozzi Carolyn R | Director | 775 | 2025-05-08 | A |
| Arbuckle Stuart A | Director | 671 | 2026-05-20 | A |
| KOBLAN KENNETH S | Officer | 357 | 2010-12-08 | — |
| Fanucci Marsha | Director | 136 | 2023-02-23 | M |
| Soni Manmeet Singh | Officer | 83 | 2018-07-10 | J |
| DZAU VICTOR J | Director | 0 | 2007-04-02 | — |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-10-02 | SUPRAN BRYAN | Open-market sale | 1,758 | $226.88 | 12,807 |
| 2026-09-19 | Greenstreet Yvonne | Grant / award | 107 | $0.00 | 95,802 |
| 2026-06-01 | Cravatt Benjamin | Grant / award (derivative) | 4,393 | $0.00 | 4,393 |
| 2026-06-01 | PYOTT DAVID E I | Option exercise (derivative) | 3,830 | $0.00 | 0 |
| 2026-06-01 | PYOTT DAVID E I | Open-market sale | 17 | $302.65 | 1,582 |
| 2026-06-01 | PYOTT DAVID E I | Open-market sale | 495 | $300.72 | 1,599 |
| 2026-06-01 | PYOTT DAVID E I | Open-market sale | 1,222 | $299.87 | 2,094 |
| 2026-06-01 | PYOTT DAVID E I | Open-market sale | 1,175 | $298.91 | 3,316 |
| 2026-06-01 | PYOTT DAVID E I | Open-market sale | 921 | $297.71 | 4,491 |
| 2026-06-01 | PYOTT DAVID E I | Option exercise | 3,830 | $0.00 | 5,412 |
| 2026-05-20 | Arbuckle Stuart A | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | Arbuckle Stuart A | Grant / award | 671 | $0.00 | 671 |
| 2026-05-20 | Ausiello Dennis A | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | Ausiello Dennis A | Grant / award | 671 | $0.00 | 1,582 |
| 2026-05-20 | BRANDICOURT OLIVIER | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | BRANDICOURT OLIVIER | Grant / award | 671 | $0.00 | 1,446 |
| 2026-05-20 | HAMBURG MARGARET A | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | HAMBURG MARGARET A | Grant / award | 671 | $0.00 | 1,582 |
| 2026-05-20 | KELLOGG PETER N | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | KELLOGG PETER N | Grant / award | 671 | $0.00 | 1,446 |
| 2026-05-20 | PYOTT DAVID E I | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | PYOTT DAVID E I | Grant / award | 671 | $0.00 | 1,582 |
| 2026-05-20 | Reitan Colleen F | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | Reitan Colleen F | Grant / award | 671 | $0.00 | 1,446 |
| 2026-05-20 | SCHULMAN AMY W | Grant / award (derivative) | 1,802 | $0.00 | 1,802 |
| 2026-05-20 | SCHULMAN AMY W | Grant / award | 838 | $0.00 | 24,049 |
| 2026-05-20 | Sigal Charles Elliott | Grant / award (derivative) | 1,441 | $0.00 | 1,441 |
| 2026-05-20 | Sigal Charles Elliott | Grant / award | 671 | $0.00 | 1,446 |
| 2026-05-13 | SCHULMAN AMY W | Option exercise (derivative) | 11,250 | $0.00 | 0 |
| 2026-05-13 | SCHULMAN AMY W | Option exercise | 11,250 | $70.20 | 23,211 |
| 2026-04-06 | McLaughlin Melissa | Open-market sale | 199 | $333.94 | 9,443 |
| 2026-04-06 | McLaughlin Melissa | Open-market sale | 293 | $331.89 | 9,642 |
| 2026-04-06 | McLaughlin Melissa | Open-market sale | 829 | $330.46 | 9,935 |
| 2026-04-06 | McLaughlin Melissa | Open-market sale | 909 | $329.76 | 10,764 |
| 2026-04-06 | McLaughlin Melissa | Open-market sale | 56 | $320.14 | 11,673 |
| 2026-04-02 | McLaughlin Melissa | Open-market sale | 8 | $325.49 | 11,729 |
| 2026-04-02 | McLaughlin Melissa | Open-market sale | 81 | $323.64 | 11,737 |
| 2026-04-02 | McLaughlin Melissa | Open-market sale | 245 | $322.86 | 11,818 |
| 2026-04-02 | McLaughlin Melissa | Open-market sale | 224 | $321.64 | 12,063 |
| 2026-04-02 | McLaughlin Melissa | Open-market sale | 147 | $320.62 | 12,287 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.